School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

First Tracks Biotherapeutics Inc TRAX

Healthcare · Biotechnology

$31.85last close 2026-10-09 · market cap $1.14B · delayed data

Trailing returns

1M-19.51%
3M-1.70%
6M+38.48%

Basis: Adjusted daily closes.

What it does

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Open TRAX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies